nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—CYP1A2—Carmustine—brain cancer	0.172	0.213	CbGbCtD
Rilpivirine—ABCG2—Carboplatin—brain cancer	0.147	0.183	CbGbCtD
Rilpivirine—CYP3A4—Temozolomide—brain cancer	0.13	0.161	CbGbCtD
Rilpivirine—ABCG2—Etoposide—brain cancer	0.124	0.153	CbGbCtD
Rilpivirine—CYP3A4—Lomustine—brain cancer	0.111	0.137	CbGbCtD
Rilpivirine—CYP1A2—Etoposide—brain cancer	0.0511	0.0633	CbGbCtD
Rilpivirine—ABCB1—Etoposide—brain cancer	0.0447	0.0553	CbGbCtD
Rilpivirine—CYP3A4—Etoposide—brain cancer	0.0268	0.0332	CbGbCtD
Rilpivirine—Etravirine—CYP2C9—brain cancer	0.00949	0.538	CrCbGaD
Rilpivirine—Pazopanib—PDGFRA—brain cancer	0.00815	0.462	CrCbGaD
Rilpivirine—Hepatotoxicity—Lomustine—brain cancer	0.00653	0.0548	CcSEcCtD
Rilpivirine—Opportunistic infection—Temozolomide—brain cancer	0.0048	0.0403	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00429	0.0762	CbGpPWpGaD
Rilpivirine—Platelet count decreased—Hydroxyurea—brain cancer	0.00416	0.035	CcSEcCtD
Rilpivirine—Transaminases increased—Carmustine—brain cancer	0.00329	0.0276	CcSEcCtD
Rilpivirine—Hepatotoxicity—Hydroxyurea—brain cancer	0.00321	0.0269	CcSEcCtD
Rilpivirine—Renal failure—Lomustine—brain cancer	0.00277	0.0233	CcSEcCtD
Rilpivirine—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.0027	0.0478	CbGpPWpGaD
Rilpivirine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00263	0.0466	CbGpPWpGaD
Rilpivirine—Creatinine increased—Hydroxyurea—brain cancer	0.0026	0.0218	CcSEcCtD
Rilpivirine—Hepatotoxicity—Carmustine—brain cancer	0.00259	0.0218	CcSEcCtD
Rilpivirine—Hepatotoxicity—Temozolomide—brain cancer	0.00251	0.021	CcSEcCtD
Rilpivirine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00239	0.0424	CbGpPWpGaD
Rilpivirine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00205	0.0363	CbGpPWpGaD
Rilpivirine—Infection—Carboplatin—brain cancer	0.00204	0.0171	CcSEcCtD
Rilpivirine—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00204	0.0361	CbGpPWpGaD
Rilpivirine—Hepatotoxicity—Etoposide—brain cancer	0.00201	0.0168	CcSEcCtD
Rilpivirine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00186	0.0331	CbGpPWpGaD
Rilpivirine—NR1I2—Nuclear Receptors—ESR2—brain cancer	0.00182	0.0322	CbGpPWpGaD
Rilpivirine—Infection—Lomustine—brain cancer	0.00179	0.015	CcSEcCtD
Rilpivirine—Blood creatinine increased—Hydroxyurea—brain cancer	0.00168	0.0141	CcSEcCtD
Rilpivirine—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.00167	0.0296	CbGpPWpGaD
Rilpivirine—Inflammation—Etoposide—brain cancer	0.0016	0.0134	CcSEcCtD
Rilpivirine—Decreased appetite—Lomustine—brain cancer	0.00156	0.0131	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00144	0.0255	CbGpPWpGaD
Rilpivirine—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00131	0.011	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.00127	0.0106	CcSEcCtD
Rilpivirine—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.00126	0.0224	CbGpPWpGaD
Rilpivirine—Alanine aminotransferase increased—Temozolomide—brain cancer	0.00124	0.0104	CcSEcCtD
Rilpivirine—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.00121	0.0215	CbGpPWpGaD
Rilpivirine—Anxiety—Procarbazine—brain cancer	0.00119	0.00997	CcSEcCtD
Rilpivirine—Dry mouth—Procarbazine—brain cancer	0.00117	0.00978	CcSEcCtD
Rilpivirine—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00115	0.0203	CbGpPWpGaD
Rilpivirine—Vomiting—Lomustine—brain cancer	0.00114	0.0096	CcSEcCtD
Rilpivirine—Infection—Procarbazine—brain cancer	0.00113	0.00952	CcSEcCtD
Rilpivirine—Depression—Carmustine—brain cancer	0.00112	0.00938	CcSEcCtD
Rilpivirine—Renal failure—Carmustine—brain cancer	0.0011	0.00924	CcSEcCtD
Rilpivirine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00109	0.0194	CbGpPWpGaD
Rilpivirine—Depression—Temozolomide—brain cancer	0.00108	0.00906	CcSEcCtD
Rilpivirine—Nausea—Lomustine—brain cancer	0.00107	0.00897	CcSEcCtD
Rilpivirine—Insomnia—Procarbazine—brain cancer	0.00103	0.00867	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Temozolomide—brain cancer	0.00102	0.00859	CcSEcCtD
Rilpivirine—Somnolence—Procarbazine—brain cancer	0.00102	0.00852	CcSEcCtD
Rilpivirine—Decreased appetite—Procarbazine—brain cancer	0.000993	0.00833	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Etoposide—brain cancer	0.000991	0.00832	CcSEcCtD
Rilpivirine—Fatigue—Procarbazine—brain cancer	0.000985	0.00826	CcSEcCtD
Rilpivirine—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000984	0.0175	CbGpPWpGaD
Rilpivirine—Urinary tract disorder—Temozolomide—brain cancer	0.00096	0.00806	CcSEcCtD
Rilpivirine—Urethral disorder—Temozolomide—brain cancer	0.000953	0.008	CcSEcCtD
Rilpivirine—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000946	0.0168	CbGpPWpGaD
Rilpivirine—Gastrointestinal pain—Procarbazine—brain cancer	0.000934	0.00784	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000916	0.00769	CcSEcCtD
Rilpivirine—Abdominal pain—Procarbazine—brain cancer	0.000903	0.00758	CcSEcCtD
Rilpivirine—Mental disorder—Carmustine—brain cancer	0.000881	0.0074	CcSEcCtD
Rilpivirine—Infection—Hydroxyurea—brain cancer	0.000878	0.00737	CcSEcCtD
Rilpivirine—Immune system disorder—Temozolomide—brain cancer	0.000878	0.00737	CcSEcCtD
Rilpivirine—Malnutrition—Carmustine—brain cancer	0.000875	0.00735	CcSEcCtD
Rilpivirine—SLCO1B1—Irinotecan Pathway—APC—brain cancer	0.000868	0.0154	CbGpPWpGaD
Rilpivirine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000867	0.0154	CbGpPWpGaD
Rilpivirine—Nervous system disorder—Hydroxyurea—brain cancer	0.000867	0.00728	CcSEcCtD
Rilpivirine—Skin disorder—Hydroxyurea—brain cancer	0.000858	0.00721	CcSEcCtD
Rilpivirine—Renal failure—Etoposide—brain cancer	0.000852	0.00715	CcSEcCtD
Rilpivirine—Mental disorder—Temozolomide—brain cancer	0.000851	0.00715	CcSEcCtD
Rilpivirine—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000846	0.015	CbGpPWpGaD
Rilpivirine—Malnutrition—Temozolomide—brain cancer	0.000846	0.0071	CcSEcCtD
Rilpivirine—Asthenia—Procarbazine—brain cancer	0.000819	0.00688	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Etoposide—brain cancer	0.000819	0.00688	CcSEcCtD
Rilpivirine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000806	0.0143	CbGpPWpGaD
Rilpivirine—ABCG2—Irinotecan Pathway—APC—brain cancer	0.000804	0.0143	CbGpPWpGaD
Rilpivirine—Somnolence—Hydroxyurea—brain cancer	0.000786	0.0066	CcSEcCtD
Rilpivirine—Diarrhoea—Procarbazine—brain cancer	0.000781	0.00656	CcSEcCtD
Rilpivirine—Decreased appetite—Hydroxyurea—brain cancer	0.000768	0.00645	CcSEcCtD
Rilpivirine—Urinary tract disorder—Etoposide—brain cancer	0.000768	0.00645	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000763	0.00641	CcSEcCtD
Rilpivirine—Urethral disorder—Etoposide—brain cancer	0.000762	0.0064	CcSEcCtD
Rilpivirine—Fatigue—Hydroxyurea—brain cancer	0.000762	0.0064	CcSEcCtD
Rilpivirine—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000759	0.0135	CbGpPWpGaD
Rilpivirine—Dizziness—Procarbazine—brain cancer	0.000755	0.00634	CcSEcCtD
Rilpivirine—Anxiety—Carmustine—brain cancer	0.000743	0.00623	CcSEcCtD
Rilpivirine—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00073	0.013	CbGpPWpGaD
Rilpivirine—Vomiting—Procarbazine—brain cancer	0.000726	0.0061	CcSEcCtD
Rilpivirine—Rash—Procarbazine—brain cancer	0.00072	0.00604	CcSEcCtD
Rilpivirine—Dermatitis—Procarbazine—brain cancer	0.000719	0.00604	CcSEcCtD
Rilpivirine—Anxiety—Temozolomide—brain cancer	0.000718	0.00603	CcSEcCtD
Rilpivirine—Headache—Procarbazine—brain cancer	0.000715	0.00601	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000715	0.006	CcSEcCtD
Rilpivirine—Infection—Carmustine—brain cancer	0.00071	0.00596	CcSEcCtD
Rilpivirine—Dry mouth—Temozolomide—brain cancer	0.000704	0.00591	CcSEcCtD
Rilpivirine—Immune system disorder—Etoposide—brain cancer	0.000702	0.0059	CcSEcCtD
Rilpivirine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000694	0.0123	CbGpPWpGaD
Rilpivirine—Infection—Temozolomide—brain cancer	0.000686	0.00576	CcSEcCtD
Rilpivirine—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000685	0.0121	CbGpPWpGaD
Rilpivirine—Nausea—Procarbazine—brain cancer	0.000678	0.00569	CcSEcCtD
Rilpivirine—Nervous system disorder—Temozolomide—brain cancer	0.000677	0.00568	CcSEcCtD
Rilpivirine—Skin disorder—Temozolomide—brain cancer	0.000671	0.00563	CcSEcCtD
Rilpivirine—Insomnia—Carmustine—brain cancer	0.000646	0.00542	CcSEcCtD
Rilpivirine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000643	0.0114	CbGpPWpGaD
Rilpivirine—Somnolence—Carmustine—brain cancer	0.000635	0.00533	CcSEcCtD
Rilpivirine—Asthenia—Hydroxyurea—brain cancer	0.000634	0.00532	CcSEcCtD
Rilpivirine—Insomnia—Temozolomide—brain cancer	0.000624	0.00524	CcSEcCtD
Rilpivirine—Decreased appetite—Carmustine—brain cancer	0.000621	0.00521	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Carmustine—brain cancer	0.000617	0.00518	CcSEcCtD
Rilpivirine—Somnolence—Temozolomide—brain cancer	0.000614	0.00515	CcSEcCtD
Rilpivirine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.00061	0.0108	CbGpPWpGaD
Rilpivirine—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000607	0.0108	CbGpPWpGaD
Rilpivirine—Diarrhoea—Hydroxyurea—brain cancer	0.000605	0.00508	CcSEcCtD
Rilpivirine—Decreased appetite—Temozolomide—brain cancer	0.0006	0.00504	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000596	0.005	CcSEcCtD
Rilpivirine—Fatigue—Temozolomide—brain cancer	0.000595	0.005	CcSEcCtD
Rilpivirine—Dizziness—Hydroxyurea—brain cancer	0.000584	0.00491	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Carmustine—brain cancer	0.000584	0.0049	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000572	0.0048	CcSEcCtD
Rilpivirine—Abdominal pain—Carmustine—brain cancer	0.000565	0.00474	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Temozolomide—brain cancer	0.000565	0.00474	CcSEcCtD
Rilpivirine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000562	0.00998	CbGpPWpGaD
Rilpivirine—Vomiting—Hydroxyurea—brain cancer	0.000562	0.00472	CcSEcCtD
Rilpivirine—Rash—Hydroxyurea—brain cancer	0.000557	0.00468	CcSEcCtD
Rilpivirine—Dermatitis—Hydroxyurea—brain cancer	0.000557	0.00467	CcSEcCtD
Rilpivirine—ABCG2—HIF-2-alpha transcription factor network—SIRT1—brain cancer	0.000555	0.00985	CbGpPWpGaD
Rilpivirine—Headache—Hydroxyurea—brain cancer	0.000554	0.00465	CcSEcCtD
Rilpivirine—Infection—Etoposide—brain cancer	0.000549	0.00461	CcSEcCtD
Rilpivirine—Abdominal pain—Temozolomide—brain cancer	0.000546	0.00458	CcSEcCtD
Rilpivirine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000543	0.00964	CbGpPWpGaD
Rilpivirine—Skin disorder—Etoposide—brain cancer	0.000537	0.0045	CcSEcCtD
Rilpivirine—Nausea—Hydroxyurea—brain cancer	0.000525	0.00441	CcSEcCtD
Rilpivirine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000524	0.0093	CbGpPWpGaD
Rilpivirine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000521	0.00925	CbGpPWpGaD
Rilpivirine—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000517	0.00918	CbGpPWpGaD
Rilpivirine—Asthenia—Carmustine—brain cancer	0.000513	0.0043	CcSEcCtD
Rilpivirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000497	0.00881	CbGpPWpGaD
Rilpivirine—Asthenia—Temozolomide—brain cancer	0.000495	0.00416	CcSEcCtD
Rilpivirine—Somnolence—Etoposide—brain cancer	0.000491	0.00412	CcSEcCtD
Rilpivirine—Diarrhoea—Carmustine—brain cancer	0.000489	0.0041	CcSEcCtD
Rilpivirine—Decreased appetite—Etoposide—brain cancer	0.00048	0.00403	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Etoposide—brain cancer	0.000477	0.004	CcSEcCtD
Rilpivirine—Fatigue—Etoposide—brain cancer	0.000476	0.004	CcSEcCtD
Rilpivirine—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000473	0.00838	CbGpPWpGaD
Rilpivirine—Dizziness—Carmustine—brain cancer	0.000472	0.00397	CcSEcCtD
Rilpivirine—Diarrhoea—Temozolomide—brain cancer	0.000472	0.00397	CcSEcCtD
Rilpivirine—Dizziness—Temozolomide—brain cancer	0.000457	0.00383	CcSEcCtD
Rilpivirine—Vomiting—Carmustine—brain cancer	0.000454	0.00381	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Etoposide—brain cancer	0.000452	0.00379	CcSEcCtD
Rilpivirine—Rash—Carmustine—brain cancer	0.00045	0.00378	CcSEcCtD
Rilpivirine—Dermatitis—Carmustine—brain cancer	0.00045	0.00378	CcSEcCtD
Rilpivirine—Headache—Carmustine—brain cancer	0.000448	0.00376	CcSEcCtD
Rilpivirine—Vomiting—Temozolomide—brain cancer	0.000439	0.00369	CcSEcCtD
Rilpivirine—Abdominal pain—Etoposide—brain cancer	0.000437	0.00367	CcSEcCtD
Rilpivirine—Rash—Temozolomide—brain cancer	0.000435	0.00365	CcSEcCtD
Rilpivirine—Dermatitis—Temozolomide—brain cancer	0.000435	0.00365	CcSEcCtD
Rilpivirine—Headache—Temozolomide—brain cancer	0.000433	0.00363	CcSEcCtD
Rilpivirine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000425	0.00754	CbGpPWpGaD
Rilpivirine—Nausea—Carmustine—brain cancer	0.000424	0.00356	CcSEcCtD
Rilpivirine—Nausea—Temozolomide—brain cancer	0.00041	0.00344	CcSEcCtD
Rilpivirine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000408	0.00725	CbGpPWpGaD
Rilpivirine—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000403	0.00715	CbGpPWpGaD
Rilpivirine—Asthenia—Etoposide—brain cancer	0.000396	0.00333	CcSEcCtD
Rilpivirine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000381	0.00675	CbGpPWpGaD
Rilpivirine—Diarrhoea—Etoposide—brain cancer	0.000378	0.00317	CcSEcCtD
Rilpivirine—Dizziness—Etoposide—brain cancer	0.000365	0.00307	CcSEcCtD
Rilpivirine—Vomiting—Etoposide—brain cancer	0.000351	0.00295	CcSEcCtD
Rilpivirine—Rash—Etoposide—brain cancer	0.000348	0.00292	CcSEcCtD
Rilpivirine—Dermatitis—Etoposide—brain cancer	0.000348	0.00292	CcSEcCtD
Rilpivirine—Headache—Etoposide—brain cancer	0.000346	0.00291	CcSEcCtD
Rilpivirine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000331	0.00587	CbGpPWpGaD
Rilpivirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.00033	0.00585	CbGpPWpGaD
Rilpivirine—Nausea—Etoposide—brain cancer	0.000328	0.00275	CcSEcCtD
Rilpivirine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000315	0.00559	CbGpPWpGaD
Rilpivirine—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000311	0.00552	CbGpPWpGaD
Rilpivirine—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000299	0.0053	CbGpPWpGaD
Rilpivirine—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000295	0.00523	CbGpPWpGaD
Rilpivirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000294	0.00521	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—S100A10—brain cancer	0.000289	0.00512	CbGpPWpGaD
Rilpivirine—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000268	0.00475	CbGpPWpGaD
Rilpivirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000256	0.00453	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000252	0.00446	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—ESR2—brain cancer	0.000248	0.0044	CbGpPWpGaD
Rilpivirine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000237	0.00421	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—brain cancer	0.000236	0.00419	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—NOTCH2—brain cancer	0.000235	0.00417	CbGpPWpGaD
Rilpivirine—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000226	0.004	CbGpPWpGaD
Rilpivirine—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000223	0.00395	CbGpPWpGaD
Rilpivirine—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000218	0.00387	CbGpPWpGaD
Rilpivirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000206	0.00365	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000194	0.00344	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000184	0.00326	CbGpPWpGaD
Rilpivirine—ABCG2—Fluoropyrimidine Activity—TP53—brain cancer	0.000183	0.00325	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000181	0.00322	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—S100A10—brain cancer	0.00018	0.00319	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000176	0.00312	CbGpPWpGaD
Rilpivirine—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000173	0.00308	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000169	0.003	CbGpPWpGaD
Rilpivirine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	0.000162	0.00288	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—PDGFRA—brain cancer	0.00014	0.00249	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	0.000139	0.00247	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000136	0.00241	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000134	0.00238	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000133	0.00236	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—DNMT1—brain cancer	0.000133	0.00236	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000124	0.00219	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—ESR2—brain cancer	0.000119	0.00212	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000117	0.00208	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—NOTCH2—brain cancer	0.000113	0.00201	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CYP2C9—brain cancer	0.000112	0.00199	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000111	0.00197	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000105	0.00186	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	9.71e-05	0.00172	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—SIRT1—brain cancer	9.61e-05	0.00171	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—BSG—brain cancer	9.53e-05	0.00169	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	9.43e-05	0.00167	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	9.37e-05	0.00166	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—TRPC6—brain cancer	8.96e-05	0.00159	CbGpPWpGaD
Rilpivirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	8.78e-05	0.00156	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	8.67e-05	0.00154	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	8.29e-05	0.00147	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—IDH1—brain cancer	8.19e-05	0.00145	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	8.01e-05	0.00142	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—MYC—brain cancer	7.82e-05	0.00139	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	7.7e-05	0.00137	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL2—brain cancer	7.66e-05	0.00136	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	7.55e-05	0.00134	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CYP2C9—brain cancer	7.53e-05	0.00134	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	7.52e-05	0.00133	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	7.45e-05	0.00132	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	7.37e-05	0.00131	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	7.21e-05	0.00128	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	7.21e-05	0.00128	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CYP2C9—brain cancer	6.97e-05	0.00124	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	6.93e-05	0.00123	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.75e-05	0.0012	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.67e-05	0.00118	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	6.6e-05	0.00117	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—VEGFA—brain cancer	6.51e-05	0.00116	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—ENO2—brain cancer	6.48e-05	0.00115	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—BSG—brain cancer	6.4e-05	0.00114	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.34e-05	0.00112	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—BSG—brain cancer	5.93e-05	0.00105	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	5.71e-05	0.00101	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—IDH1—brain cancer	5.5e-05	0.000976	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	5.37e-05	0.000953	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CYP2C9—brain cancer	5.11e-05	0.000906	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—IDH1—brain cancer	5.1e-05	0.000904	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.94e-05	0.000876	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	4.48e-05	0.000795	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.48e-05	0.000795	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ENO2—brain cancer	4.35e-05	0.000772	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—BSG—brain cancer	4.34e-05	0.000771	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	4.17e-05	0.00074	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ENO2—brain cancer	4.03e-05	0.000715	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CYP2C9—brain cancer	3.86e-05	0.000685	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CYP2C9—brain cancer	3.77e-05	0.000668	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—MYC—brain cancer	3.77e-05	0.000668	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—IDH1—brain cancer	3.74e-05	0.000663	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	3.69e-05	0.000654	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	3.65e-05	0.000647	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—BSG—brain cancer	3.28e-05	0.000582	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	3.21e-05	0.00057	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—BSG—brain cancer	3.2e-05	0.000568	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CYP2C9—brain cancer	3.01e-05	0.000534	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PIK3CG—brain cancer	2.97e-05	0.000527	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.96e-05	0.000524	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ENO2—brain cancer	2.95e-05	0.000524	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.89e-05	0.000513	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—IDH1—brain cancer	2.82e-05	0.000501	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—IDH1—brain cancer	2.76e-05	0.000489	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—BSG—brain cancer	2.56e-05	0.000454	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.43e-05	0.000431	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CYP2C9—brain cancer	2.32e-05	0.000412	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.3e-05	0.000408	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ENO2—brain cancer	2.23e-05	0.000396	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—IDH1—brain cancer	2.2e-05	0.00039	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ENO2—brain cancer	2.18e-05	0.000386	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3CG—brain cancer	2e-05	0.000354	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—BSG—brain cancer	1.97e-05	0.00035	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3CG—brain cancer	1.85e-05	0.000328	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.79e-05	0.000318	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ENO2—brain cancer	1.74e-05	0.000308	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—IDH1—brain cancer	1.7e-05	0.000301	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3CG—brain cancer	1.35e-05	0.00024	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ENO2—brain cancer	1.34e-05	0.000238	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3CG—brain cancer	1.02e-05	0.000182	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3CG—brain cancer	9.99e-06	0.000177	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3CG—brain cancer	7.98e-06	0.000141	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3CG—brain cancer	6.16e-06	0.000109	CbGpPWpGaD
